Daewoong gets US prequalification approval for carbapenem antibiotic

A Korean antibiotic drug has won prequalification approval from the Food and Drug Administration of the United States for sale in the country, the company said Monday, a move that will give the local drugmaker access to the world’s largest market.

The drug developed by Daewoong Pharmaceutical Co., one of the major Korean drugmakers, is a generic version of meropenem trihyrate of Dainippon Su...